Business Qa & Gmp 29 May2010

1. Regulatory and QA Considerations for Drug Product Development Louise Johnson, M.S. Chinese American Biopharmaceutical Society Meeting June 5, 2010 2. Core Principles Patient…

Documents Presentation on regulatory affairs 30032013

1. Regulatory AffairsDr. Nishodh Saxena30th March 2013 2. Data in the dossier should enable us to answer the following questions What is the product? Is the quality…

Documents ASMF 01-00-2012- AP

Cambrex Profarmaco Milano S.r.l. EMTRICITABINE ACTIVE SUBSTANCE MASTER FILE Ed. 01.00/2012-ASMF NEW SUBMISSION OCTOBER 2012 Cambrex Profarmaco Milano S.r.l. Emtricitabine,…

Documents Common Deficiencies in submissions for Prequalification (Quality part) HUA YIN Prequalification of.....

Slide 1 Common Deficiencies in submissions for Prequalification (Quality part) HUA YIN Prequalification of Medicines Programme QSM / EMP / HSS WHO prequalification programme:…